首页> 外文期刊>Diabetes >Thiazolidinedione Compounds Ameliorate Glomerular Dysfunction Independent of Their Insulin-Sensitizing Action in Diabetic Rats
【24h】

Thiazolidinedione Compounds Ameliorate Glomerular Dysfunction Independent of Their Insulin-Sensitizing Action in Diabetic Rats

机译:噻唑烷二酮类化合物可改善肾小球功能障碍,独立于其在糖尿病大鼠中的胰岛素敏感性作用

获取原文
获取原文并翻译 | 示例
       

摘要

Thiazolidinedione (TZD) compounds are widely used as oral hypoglycemic agents. Herein, we provide evidence showing that troglitazone, one of the TZD compounds, is able to prevent glomerular dysfunction in diabetic rats through a novel mechanism independent of its insulin-sensitizing action. We examined the effect of troglitazone on functional and biochemical parameters of glomeruli in streptozotocin-induced diabetic rats.
机译:噻唑烷二酮(TZD)化合物被广泛用作口服降糖药。本文中,我们提供的证据表明曲格列酮(一种TZD化合物)能够通过一种独立于其胰岛素增敏作用的新机制来预防糖尿病大鼠的肾小球功能障碍。我们检查了曲格列酮对链脲佐菌素诱导的糖尿病大鼠肾小球功能和生化参数的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号